When the drug binds to CD47, it helps destroy the cancer cells directly. In the study, magrolimab was combined with docetaxel, a type of chemotherapy. The study included 31 patients with metastatic ...

For example, ongoing trials are examining whether cabazitaxel is more effective and better tolerated than docetaxel for first-line chemotherapy for mCRPC. Earlier in the disease course ...

Reason for decision Anticipate the topic will be of importance to patients, carers, professionals, commissioners and the health of the public to ensure clinical benefit is realised, inequalities in ...

The US regulator has approved Nubeqa (darolutamide) in combination with docetaxel chemotherapy for the treatment of metastatic hormone-sensitive prostate cancer (mHSPC), adding to its earlier ...

Adding an anthracycline to adjuvant chemotherapy for TOP2A-normal early breast cancer significantly improved disease-free survival (DFS) but not overall survival (OS) at 10 years, and doubled the risk ...

Abiraterone acetate plus prednisone also improves rPFS and enzalutamide improves rPFS and OS in chemotherapy-naive CRPC patients. Docetaxel plus prednisone as a first-line chemotherapy ...

Novocure has refined the transducer arrays that attach to Optune Gio, its wearable for glioblastoma treatment.

The battle against breast cancer has produced significant triumphs in recent years, with new and tailored treatments now ...

The FDA has accepted a supplemental new drug application for the combination of darolutamide and androgen deprivation therapy for the treatment of patients with metastatic hormone-sensitive prostate ...

1 “If approved, this would expand the indication for [darolutamide] in patients with mHSPC to include [darolutamide] both ...

Bayer's efforts to expand Nubeqa's label in prostate cancer make progress with the FDA's acceptance of the company's sNDA.